Evaluation of Botulinum TOXin Type a in the Treatment of Buerger's Disease

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Buerger DiseaseRaynaud Syndrome
Interventions
DRUG

BOTOX INJECTION

"The patient will be treated with a single session with botulinum toxin A injections at the hospital, and the judgmental criteria will be assessed at 1, 3 and 6 months post injections.~The injections will be made in 4 injection points at the palmar or distal plantar fold, at the level of the neurovascular beams, 2h after topical anesthesia by lidocaine cream under occlusion, associated or not with nitrous oxide inhaled at the time of the injections (BOTOX® 100 U).~In the event of multiple lesions, a single limb is injected based on clinical severity (ulcer, gangrene) and ischemia parameters (lowest TCPO2)."

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER